Literature DB >> 3780999

Endometrial tissue in peritoneal fluid.

D Bartosik, S L Jacobs, L J Kelly.   

Abstract

Peritoneal fluid (PF) was studied for the presence of endometrial tissue in a consecutive series of 67 women (with documented tubal patency) undergoing diagnostic laparoscopy, tubal lavage, and hysteroscopy. PF was completely aspirated from the cul-de-sac both before and after uterine irrigation. The PF was then analyzed for the presence of endometrial tissue. In native PF no significant difference in the incidence of endometrial tissue between patients with (19%) and without (11%) endometriosis (P = 0.6) was observed. Refluxed PF, obtained after uterine irrigation, showed a significantly higher incidence of endometrial tissue in women with endometriosis (76%) as compared to controls (42%) (P = 0.03). We propose two models to explain the development of endometriosis. These are not mutually exclusive, may be independent of each other, and may represent two distinct pathophysiologic disease processes.

Entities:  

Mesh:

Year:  1986        PMID: 3780999     DOI: 10.1016/s0015-0282(16)49813-4

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  12 in total

1.  Immune-inflammation gene signatures in endometriosis patients.

Authors:  Soo Hyun Ahn; Kasra Khalaj; Steven L Young; Bruce A Lessey; Madhuri Koti; Chandrakant Tayade
Journal:  Fertil Steril       Date:  2016-07-27       Impact factor: 7.329

2.  Lactobacillus gasseri OLL2809 is effective especially on the menstrual pain and dysmenorrhea in endometriosis patients: randomized, double-blind, placebo-controlled study.

Authors:  Hiroyuki Itoh; Masayuki Uchida; Toshihiro Sashihara; Zai-Si Ji; Ji Li; Qianjue Tang; Shuang Ni; Linyi Song; Shuichi Kaminogawa
Journal:  Cytotechnology       Date:  2010-12-10       Impact factor: 2.058

3.  Interleukin-12 inhibits development of ectopic endometriotic tissues in peritoneal cavity via activation of NK cells in a murine endometriosis model.

Authors:  Hiroyuki Itoh; Toshihiro Sashihara; Akira Hosono; Shuichi Kaminogawa; Masayuki Uchida
Journal:  Cytotechnology       Date:  2011-03-15       Impact factor: 2.058

4.  Tyrosine receptor kinase B (TrkB) protein expression in the human endometrium.

Authors:  Dana L Anger; Bingjun Zhang; Odette Boutross-Tadross; Warren G Foster
Journal:  Endocrine       Date:  2007-04       Impact factor: 3.633

5.  Apoptosis resistance in endometriosis.

Authors:  Ali Salmassi; Bengi Acar-Perk; Andreas G Schmutzler; Kerstin Koch; Frank Püngel; Walter Jonat; Liselotte Mettler
Journal:  Bioimpacts       Date:  2011-08-06

6.  Aberrant gene expression profile in a mouse model of endometriosis mirrors that observed in women.

Authors:  Katherine E Pelch; Amy L Schroder; Paul A Kimball; Kathy L Sharpe-Timms; J Wade Davis; Susan C Nagel
Journal:  Fertil Steril       Date:  2009-05-26       Impact factor: 7.329

7.  Augmented cell survival in eutopic endometrium from women with endometriosis: expression of c-myc, TGF-beta1 and bax genes.

Authors:  M Cecilia Johnson; Marisa Torres; Alessandra Alves; Ketty Bacallao; Ariel Fuentes; Margarita Vega; M Angélica Boric
Journal:  Reprod Biol Endocrinol       Date:  2005-09-08       Impact factor: 5.211

8.  Quantity and quality of retrograde menstruation: a case control study.

Authors:  Attila Bokor; Sophie Debrock; Maria Drijkoningen; Willy Goossens; Vilmos Fülöp; Thomas D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2009-10-30       Impact factor: 5.211

9.  Evaluation of the risk of spreading endometrial cell by hysteroscopy: a prospective longitudinal study.

Authors:  Rievani de Sousa Damião; Reginaldo Guedes Coelho Lopes; Emilly Serapião Dos Santos; Umberto Gazzi Lippi; Eduardo Borges da Fonseca
Journal:  Obstet Gynecol Int       Date:  2009-05-25

Review 10.  Potential involvement of the immune system in the development of endometriosis.

Authors:  Cleophas M Kyama; Sophie Debrock; Jason M Mwenda; Thomas M D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2003-12-02       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.